Search
for
Sort by
Research 18
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Long COVID syndrome: An unfolding enigma
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- The Role of Neurorehabilitation in Post-COVID-19 Syndrome
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- How drug repurposing can advance drug discovery: challenges and opportunities
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- GRADE guidance 36: updates to GRADE's approach to addressing inconsistency
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- A narrative review of SARS-CoV-2 variants and long COVID
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Exploring the mechanism of Platycladi Cacumen in intervening androgenetic alopecia based on network pharmacology, molecular docking, and molecular dynamics simulation